Publication | Closed Access

Lung Function Response to 12-week Treatment with Combined Inhalation of Long-acting β2 Agonist and Glucocorticoid According to ADRB2 Polymorphism in Patients with Chronic Obstructive Pulmonary Disease

AsthmaAdvanced Lung DiseaseLung InflammationPulmonary PhysiologyPulmonary PharmacologyLung MechanicsPulmonary MedicineLong-acting β2 AgonistAdrb2 PolymorphismMedicinePulmonary DiseaseLung Function Response